As all previous studies on the prognostic relevance of p27 expression in prostate cancer have analyzed comparatively small tumor sets with a maximum of 130 patients, it is possible that the analysis of large cohorts may provide clearer results. This evidence concerns the gene CDKN1B and Familial prostate cancer.